SVLSF V, LLC
Insider CIK 1644160 · STRO 10% owner · CATB 10% owner · ASNS 10% owner · BCYC 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCYC BICYCLE THERAPEUTICS plc | C Conversion deriv | 2019-05-28 | 2019-05-30 | 874,709 | — | $0 | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | C Conversion deriv | 2019-05-28 | 2019-05-30 | 623,196 | — | $0 | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | C Conversion deriv | 2019-05-28 | 2019-05-30 | 13,169 | — | $0 | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | C Conversion deriv | 2019-05-28 | 2019-05-30 | 18,485 | — | $0 | 0 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | P Buy | 2019-05-28 | 2019-05-30 | 377,732 | $14.00 | $5.29M | 1,875,637 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | C Conversion | 2019-05-28 | 2019-05-30 | 18,485 | — | $0 | 18,485 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | C Conversion | 2019-05-28 | 2019-05-30 | 623,196 | — | $0 | 1,497,905 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | C Conversion | 2019-05-28 | 2019-05-30 | 874,709 | — | $0 | 874,709 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | P Buy | 2019-05-28 | 2019-05-30 | 7,983 | $14.00 | $111.8K | 39,637 | SEC↗ |
| BCYC BICYCLE THERAPEUTICS plc | C Conversion | 2019-05-28 | 2019-05-30 | 13,169 | — | $0 | 31,654 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 64,815 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 141,249 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 194,786 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 9,155,794 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 6,683,697 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 9,217,015 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 52,183 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 106,019 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 17,533 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 5,462,550 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 11,097,596 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 1,835,270 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 193,492 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 131,683 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion deriv | 2018-10-01 | 2018-10-01 | 21,776 | — | $0 | 0 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 251,783 | — | $0 | 863,503 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 270,690 | — | $0 | 611,720 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 341,030 | — | $0 | 341,030 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 1,931 | — | $0 | 8,817 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 6,128 | — | $0 | 6,886 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 758 | — | $0 | 758 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 202,115 | — | $0 | 923,022 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 641,440 | — | $0 | 720,907 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 79,467 | — | $0 | 79,467 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 2,399 | — | $0 | 10,952 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 7,610 | — | $0 | 8,553 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 943 | — | $0 | 943 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 5,320 | — | $0 | 18,248 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 5,721 | — | $0 | 12,928 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | C Conversion | 2018-10-01 | 2018-10-01 | 7,207 | — | $0 | 7,207 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | M Exercise deriv | 2018-09-27 | 2018-10-01 | 6,183 | — | $0 | 5,361 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | M Exercise deriv | 2018-09-27 | 2018-10-01 | 6,183 | — | $0 | 64,815 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | M Exercise deriv | 2018-09-27 | 2018-10-01 | 521,159 | — | $0 | 451,869 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | M Exercise deriv | 2018-09-27 | 2018-10-01 | 4,978 | — | $0 | 52,183 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | M Exercise deriv | 2018-09-27 | 2018-10-01 | 4,978 | — | $0 | 4,315 | SEC↗ |
| STRO SUTRO BIOPHARMA INC | M Exercise deriv | 2018-09-27 | 2018-10-01 | 521,159 | — | $0 | 5,462,550 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 65,287 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 1,380 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 690,259 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 14,587 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 721,402 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 15,246 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 224,665 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 4,747 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 692,552 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 14,635 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 1,474,348 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion deriv | 2017-11-20 | 2017-11-20 | 50,477 | — | $0 | 0 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 111,955 | — | $0 | 712,624 | SEC↗ |
| ASNS Arsanis, Inc. | P Buy | 2017-11-20 | 2017-11-20 | 483,448 | $10.00 | $4.83M | 1,852,409 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 14,789 | — | $0 | 1,368,961 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 431,980 | — | $0 | 1,354,172 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 4,288 | — | $0 | 922,192 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 202,915 | — | $0 | 917,904 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 2,365 | — | $0 | 714,989 | SEC↗ |
| ASNS Arsanis, Inc. | P Buy | 2017-11-20 | 2017-11-20 | 16,552 | $10.00 | $165.5K | 1,868,961 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 6,806 | — | $0 | 600,669 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 322,102 | — | $0 | 593,863 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 5,219 | — | $0 | 271,761 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 247,010 | — | $0 | 266,542 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 404 | — | $0 | 19,532 | SEC↗ |
| ASNS Arsanis, Inc. | C Conversion | 2017-11-20 | 2017-11-20 | 19,128 | — | $0 | 19,128 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 9,821,385 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 21,218,253 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 448,414 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion deriv | 2015-06-30 | 2015-06-30 | 207,558 | — | $0 | 0 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 34,893 | — | $0 | 34,893 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 1,651,223 | — | $0 | 1,651,223 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | P Buy | 2015-06-30 | 2015-06-30 | 8,094 | $12.00 | $97.1K | 59,139 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 764,309 | — | $0 | 2,415,532 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | P Buy | 2015-06-30 | 2015-06-30 | 382,996 | $12.00 | $4.60M | 2,798,528 | SEC↗ |
| CATB CATABASIS PHARMACEUTICALS | C Conversion | 2015-06-30 | 2015-06-30 | 16,152 | — | $0 | 51,045 | SEC↗ |